|
[1]YANG Y Q,XIAO T S,LI J R,et al. Wild‐type cutoff for apramycin against Escherichia coli[J]. BMC Veterinary Research,2020,16(1):309.
[2]RILEY L W. Distinguishing pathovars from nonpathovars:Escherichia coli[J].Microbiology Spectrum,2020,8(4):10.
[3]WILSON J,ELGOHARI S,LIVERMORE D M,et al.Trends among pathogens reported as causing bacteraemia in England,2004—2008[J]. Clinical Microbiology and Infection,2011,17(3):451‐458.
[4]李海利,徐引弟,王治方,等. 胶冻样芽孢杆菌对革兰氏阴性菌的抑菌活性及其抗菌次级代谢产物分析[J]. 河南农业科学,2024,53(10):159‐169.
LI H L,XU Y D,WANG Z F,et al. Analysis of antibacterial activity and secondary metabolites of Paenibacillus kribbensis against gram‐negative bacteria[J]. Journal of Henan Agricultural Sciences,2024,53 (10):159‐169.
[5]闫安龙,张亚南,王帝,等. 国内部分地区猪禽粪便中产气荚膜梭菌的分离鉴定、耐药性及生物被膜形成能力分析[J/OL].中国动物传染病学报,2025[2025‐03‐23].https://doi. org/10. 19958/j. cnki. cn31‐2031/s.20250126.001.
YAN A L,ZHANG Y N,WANG D,et al. Isolation,identification and biological characteristics of Clostridium perfringens in pig and poultry manure[J/OL].Chinese Journal of Animal Infectious Diseases,2025[2025‐03‐23].https://doi. org/10. 19958/j. cnki.cn31‐2031/s. 20250126. 001.
[6]LIVERMORE D M,HOPE R,BRICK G,et al.Non‐susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland,2001‐06[J].Journal of Antimicrobial Chemotherapy,2008,62(S2):ii41‐ii54.
[7]聂阿真,倪子富,冯先阳,等. 醋糟乳酸菌的筛选、鉴定及其益生特性研究[J]. 河南农业大学学报,2025,59(5):859‐871.
NIE A Z,NI Z F,FENG X Y,et al. Screening,identification and probiotic properties of lacticacid bacteria from vinegar lees[J]. Journal of Henan Agricultural University,2025,59(5):859‐871.
[8]张文刚,严凤,姜芹,等. 某地养殖场大肠杆菌耐药率与粪便中抗菌药物残留情况的初步分析[J].上海畜牧兽医通讯,2019(2):48‐49.
ZHANG W G,YAN F,JIANG Q,et al. Preliminary analysis on the drug resistance rate of Escherichia coli in a farm and the residue of antibacterial drugs in feces[J]. Shanghai Journal of Animal Husbandry and Veterinary Medicine,2019(2):48‐49.
[9]BARTON M D. Impact of antibiotic use in the swine industry[J]. Current Opinion in Microbiology,2014,19:9‐15.
[10]HALL C W,MAH T F. Molecular mechanisms of biofilm‐based antibiotic resistance and tolerance in pathogenic bacteria[J]. FEMS Microbiology Reviews,2017,41(3):276‐301.
[11]LOHSE M B,GULATI M,JOHNSON A D,et al.Development and regulation of single‐and multi‐species Candida albicans biofilms[J]. Nature Reviews Microbiology,2018,16(1):19‐31.
[12]ROY R,TIWARI M,DONELLI G,et al. Strategies for combating bacterial biofilms:A focus on anti‐biofilm agents and their mechanisms of action[J]. Virulence,2018,9(1):522‐554.
[13]MORYL M,RÓŻALSKI A,DE FIGUEIREDO J A P,et al. How do phages disrupt the structure of Enterococcus faecalis biofilm?[J].International Journal of Molecular Sciences,2023,24(24):17260.
[14]ÖZTÜRK F Y,DARCAN C,KARIPTAŞ E. The determination,monitoring,molecular mechanisms and formation of biofilm in E.coli[J]. Brazilian Journal of Microbiology,2023,54(1):259‐277.
[15]HØIBY N,BJARNSHOLT T,MOSER C,et al. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014 [J]. Clinical Microbiology and Infection,2015,21(S1):S1‐S25.
[16]MITTAL S,SHARMA M,CHAUDHARY U. Biofilm and multidrug resistance in uropathogenic Escherichia coli[J]. Pathogens and Global Health,2015,109(1):26‐29.
[17]周杰,牟航,王舒博,等. 重庆地区畜禽源大肠杆菌耐药性变化分析[J]. 南方农业学报,2024,55(10):3179‐3189.
ZHOU J,MOU H,WANG S B,et al. Changes in drug resistance of poultry and livestock sourced Escherichia coli in Chongqing[J]. Journal of Southern Agriculture,2024,55(10):3179‐3189.
[18]GIBB B P,ADJIARGYROU M. Bacteriophage therapy for bone and joint infections[J]. The Bone & Joint Journal,2021,103‐B(2):234‐244.
[19]STRATHDEE S A,HATFULL G F,MUTALIK V K,et al. Phage therapy:From biological mechanisms to future directions[J]. Cell,2023,186(1):17‐31.
[20]CAMARILLO‐GUERRERO L F,ALMEIDA A,RANGEL‐PINEROS G,et al. Massive expansion of human gut bacteriophage diversity[J].Cell,2021,184 (4):1098‐1109.
[21]DION M B,OECHSLIN F,MOINEAU S. Phage diversity,genomics and phylogeny[J]. Nature Reviews Microbiology,2020,18(3):125‐138.
[22]REA M C,DOBSON A,O’SULLIVAN O,et al. Effect of broad‐and narrow‐spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon[J]. Proceedings of the National Academy of Sciences of the United States of America,2011,108(S1):4639‐4644.
[23]于华波,张亮,冯超,等. 噬菌体药代动力学研究进展[J].中国兽医学报,2022,42(2):399‐404.
YU H B,ZHANG L,FENG C,et al. Advances in phage pharmacokinetics[J]. Chinese Journal of Veterinary Science,2022,42(2):399‐404.
[24]王冰,李阳,黄安琪,等. 噬菌体防治食品中食源性致病菌的研究进展[J]. 食品研究与开发,2024,45(15):204‐209.
WANG B,LI Y,HUANG A Q,et al.Research progress on the use of bacteriophages in controlling foodborne
pathogens in foods[J].Food Research and Development,2024,45(15):204‐209.
[25]刘子琛,陈婷,张永亮. 噬菌体在畜牧生产中的研究应用进展[J]. 畜牧与兽医,2024,56(12):139‐146.
LIU Z C,CHEN T,ZHANG Y L. Progress in research on application of bacteriophages in poultry and livestock production[J]. Animal Husbandry & Veterinary Medicine,2024,56(12):139‐146.
[26]LU R M,HWANG Y C,LIU I J,et al. Development of therapeutic antibodies for the treatment of diseases [J]. Journal of Biomedical Science,2020,27(1):1.
[27]CHEN Q Q,DHARMARAJ T,CAI P C,et al.Bacteriophage and bacterial susceptibility,resistance,and tolerance to antibiotics[J]. Pharmaceutics,2022,14(7):1425.
[28]陈坤,王成森,钱淼,等. 一株新的防治大肠杆菌O157:H7的烈性噬菌体特性及其应用研究[J].食品科技,2025,50(9):28‐35.
CHEN K,WANG C S,QIAN M,et al. Biological characteristic and application of a novel lytic bacteriophage against Escherichia coli O157:H7[J].Food Science and Technology,2025,50(9):28‐35.
[29]ALEXYUK P,BOGOYAVLENSKIY A,ALEXYUK M,et al. Isolation and characterization of lytic bacteriophages active against clinical strains of E.coli and development of a phage antimicrobial cocktail[J].Viruses,2022,14(11):2381.
[30]SULTAN‐ALOLAMA M I,AMIN A,EL‐TARABILY K A,et al.Characterization and genomic analysis of Escherichia coli O157:H7 phage UAE_MI‐01 isolated from birds[J].International Journal of Molecular Sciences,2022,23(23):14846.
[31]KORTRIGHT K E,CHAN B K,KOFF J L,et al. Phage therapy: A renewed approach to combat antibiotic‐resistant bacteria[J]. Cell Host & Microbe,2019,25(2):219‐232.
[32]JUN J W,GIRI S S,KIM H J,et al. Bacteriophage application to control the contaminated water with Shigella[J]. Scientific Reports,2016,6:22636.
[33]KIM H J,GIRI S S,KIM S G,et al.Isolation and characterization of two bacteriophages and their preventive effects against pathogenic Vibrio coralliilyticus causing mortality of Pacific oyster(Crassostrea gigas)larvae[J].Microorganisms,2020,8 (6):926.
[34]BUTTIMER C,LYNCH C,HENDRIX H,et al.Isolationand characterization of Pectobacterium Phage vB_PatM_CB7:New insights into the genus Certrevirus[J].Antibiotics,2020,9(6):352.
[35]刘亮. 蛋鸡禽致病性大肠杆菌分离鉴定及噬菌体制剂体外杀菌研究[J].畜禽业,2024,35(2):13‐16.
LIU L. Isolation and identification of pathogenic Escherichia coli from laying hens and in vitro sterilization of phage preparation[J].Livestock and Poultry Industry,2024,35(2):13‐16.
[36]DENG H W,LI M J,ZHANG Q Y,et al. The broad‐spectrum endolysin LySP2 improves chick survival after Salmonella pullorum infection[J].Viruses,2023,15(4):836.
[37]WU Z F,ZHANG Y,XU X Y,et al.The Holin‐endolysin lysis system of the OP2‐like phage X2 infecting Xanthomonas oryzae pv.oryzae[J]. Viruses,2021,13(10):1949.
[38]CHAMBLEE J S,RAMSEY J,CHEN Y,et al. Endolysin regulation in phage Mu lysis[J].mBio,2022,13(3):e0081322.
[39]RAJAURE M,BERRY J,KONGARI R,et al. Membrane fusion during phage lysis[J].Proceedings of the National Academy of Sciences of the United States of America,2015,112(17):5497‐5502.
[40]YOUNG R. Phage lysis:Three steps,three choices,one outcome[J]. Journal of Microbiology,2014,52(3):243‐258.
[41]PIRES D P,OLIVEIRA H,MELO L D R,et al.Bacteriophage‐encoded depolymerases:Their diversity and biotechnological applications [J].Applied Microbiology and Biotechnology,2016,100(5) :2141‐2151.
[42]周玲玲,王宇航,撒俊梦,等. 抗菌肽LL-1体内治疗大肠杆菌感染的效果[J].河南农业科学,2025,54(5):142‐148.
ZHOU L L,WANG Y H,SA J M,et al. Treatment effect of antimicrobial peptide LL‐1 on E.coli infection in vivo[J]. Journal of Henan Agricultural Sciences,2025,54(5):142‐148.
[43]LU H,NI S Q. Review on sterilization techniques,and the application potential of phage lyase and lyase immobilization in fighting drug‐resistant bacteria[J].Journal of Materials Chemistry B,2024,12(14):3317‐3335.
[44]BALLÉN V,CEPAS V,RATIA C,et al. Clinical Escherichia coli:From biofilm formation to new antibiofilm strategies[J]. Microorganisms,2022,10(6):1103.
[45]GONZÁLEZ J F,HAHN M M,GUNN J S. Chronic biofilm‐based infections:Skewing of the immune response[J]. Pathogens and Disease,2018,76(3):fty023.
[46]JDEED G,KRAVCHUK B,TIKUNOVA N V. Factors affecting phage‐bacteria coevolution dynamics[J].Viruses,2025,17(2):235.
[47]KIM B O,KIM E S,YOO Y J,et al. Phage‐derived antibacterials:Harnessing the simplicity,plasticity,and diversity of phages[J]. Viruses,2019,11(3):268.
[48]刘敏,齐海涛,袁辉,等. 厦门希瓦氏菌噬菌体的分离、表征和应用研究[J]. 动物医学进展,2025,46(2):47‐53.
LIU M,QI H T,YUAN H,et al. Isolation,characterization and application of a phage from Shewanella xiamenensis[J]. Progress in Veterinary Medicine,2025,46(2):47‐53.
|